Backed by Johnson & Johnson’s venture arm, among others, Arialys plans to take a medicine it acquired from Astellas Pharma into clinical testing next year.A new biotechnology company with tens of millions of dollars in funding aims to develop more precise treatments for so-called neuropsychiatric disorders.Launched on Tuesday, Arialys Therapeutics says it was founded on […]
